THE CAR-T PATIENT'S TRUTH; INSIGHTS FROM PATIENTS, CAREGIVERS AND HCPS BEFORE, DURING AND AFTER GENE/CAR-T THERAPY FOR THEIR CANCER

被引：0
|
作者：
Reeder, K. [1 ]
Smith, R. [1 ]
Learn, C. [1 ]
Norwood, C. [1 ]
Caldwell, L. [1 ]
机构：
[1] Parexel Int Corp, Patient Innovat Ctr, Newton, MA USA
来源：
CYTOTHERAPY | 2023年 / 25卷 / 06期
关键词：
patient journey; voice of patient; patient advocacy;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
715
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [21] Long-term Survivors and Failures of CAR-T Therapy for Lymphoma: Is there a Role for Allogeneic Transplantation After the CAR-T Crash?
    Spinner, Michael A.
    Komanduri, Krishna, V
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (12): : 725 - 726
  • [22] Successful treatment of severe cytokine release syndrome after CAR-T therapy by ruxolitinib without compromising CAR-T efficacy
    Gu, Chengyuan
    Wu, Qian
    Zhang, Jingren
    Kang, Liqing
    Yu, Lei
    Qiu, Huiying
    Wu, Depei
    Chen, Suning
    Yang, Xiaofei
    LEUKEMIA & LYMPHOMA, 2023, 64 (02) : 495 - 498
  • [23] Cystic degeneration of a lipoma in a patient treated with CAR-T therapy
    Paradkar, Komal
    Krispinsky, Andrew
    Dulmage, Brittany
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (03) : E182 - E184
  • [24] CAR-T Cell Therapy: From the Bench to the Bedside
    Golubovskaya, Vita
    CANCERS, 2017, 9 (11):
  • [25] Redefining chimeric antigen receptor T-cell (CAR-T) regulation: China's responses to address secondary cancer risks of CAR-T therapy
    Tan, Ruirong
    Li, Rui
    Dai, Meng-Yuan
    Liu, Miao
    Zhao, Junning
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
  • [26] CAR-T cell therapy in ovarian cancer: from the bench to the bedside
    Zhu, Xinxin
    Cai, Han
    Zhao, Ling
    Ning, Li
    Lang, Jinghe
    ONCOTARGET, 2017, 8 (38) : 64607 - 64621
  • [27] Gene Modified CAR-T Cellular Therapy for Hematologic Malignancies
    Lin, Wen-Ying
    Wang, Hsin-Hui
    Chen, Yi-Wei
    Lin, Chun-Fu
    Fan, Hueng-Chuen
    Lee, Yi-Yen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 21
  • [28] Reducing the risk of biocontamination in gene, cell and CAR-T therapy
    Hansen, Rolf
    Manufacturing Chemist, 2020, 91 (10): : 30 - 31
  • [29] Immune determinants of CAR-T expansion in solid tumor patients receiving GD2 CAR-T cell therapy
    Murty, Tara
    Kaczanowska, Sabina
    Alimadadi, Ahmad
    Contreras, Cristina
    Duault, Caroline
    Balasubrahmanyan, Priyanka
    Reynolds, Warren
    Gutierrez, Norma
    Baskar, Reema
    Wu, Catherine
    Michor, Franziska
    Altreuter, Jennifer
    Liu, Yang
    Jhaveri, Aashna
    Duong, Vandon
    Anbunathan, Hima
    Moravec, Radim
    Hong, Joyce
    Biswas, Roshni
    Van Nostrand, Stephen
    Lindsay, James
    Pichavant, Mina
    Sotillo, Elena
    Sahaf, Bita
    Bendall, Sean
    Maecker, Holden
    Highfill, Steven
    Stroncek, David
    Merchant, Melinda
    Glod, John
    Hedrick, Catherine
    Mackall, Crystal
    Ramakrishna, Sneha
    Kaplan, Rosandra
    CANCER RESEARCH, 2023, 83 (07)
  • [30] Case report: Sandwich therapy of CAR-T combined with ASCT: Sequential CAR-T cell therapy with ASCT after remission with CAR-T therapy caused long-term survival in a patient with relapsed/refractory Burkitt's lymphoma with TP53 mutations
    Zhang, Qi
    Zhu, Xiaojian
    Liu, Bo
    Zhang, Yicheng
    Xiao, Yi
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345